Long-term prognosis after myocardial infarction in men with diabetes

Diabetes
|August 1, 1985
PubMed

Insights

Men with diabetes surviving a first myocardial infarction (MI) face significantly lower survival rates and higher reinfarction risks. Diabetes is an independent secondary risk factor for male MI survivors.

Area of Science:

  • Cardiology
  • Endocrinology
  • Public Health

Background:

  • Myocardial infarction (MI) is a leading cause of mortality in men.
  • The impact of diabetes mellitus on long-term outcomes for male MI survivors requires further investigation.
  • Understanding secondary risk factors is crucial for improving post-MI management.

Purpose of the Study:

  • To compare the outcomes of male survivors of a first myocardial infarction (MI) with and without diabetes.
  • To determine if diabetes is an independent risk factor for mortality and reinfarction after MI.
  • To analyze the influence of diabetes on cumulative survival and reinfarction rates.

Main Methods:

  • A cohort study of 1306 men who survived a first MI.
  • Mean follow-up of 6.5 years with complete survival status data.
  • Comparison of survival rates and reinfarction cumulative rates between diabetic and non-diabetic patients using multivariate regression analysis.

Main Results:

  • The prevalence of diabetes at the time of MI was 5.6%.
  • Diabetic subjects had significantly lower cumulative survival rates (5-year: 58% vs. 82%) and higher reinfarction rates (5-year: 46% vs. 27%) compared to non-diabetic subjects (P < 0.001 and P = 0.004, respectively).
  • Diabetes was identified as an independent secondary risk factor for both mortality and reinfarction, even after adjusting for age and other secondary risks.

Conclusions:

  • Diabetes is a significant independent secondary risk factor in male survivors of a first myocardial infarction.
  • Diabetic male MI survivors experience substantially worse long-term outcomes, including increased mortality and reinfarction rates.
  • These findings underscore the importance of aggressive diabetes management in cardiovascular disease prevention and post-MI care.

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Myocarditis IV: Nursing Management01:22

Myocarditis IV: Nursing Management

Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...